PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26/08/26	NT$11.35	+2.25%	192,322
25/08/26	NT$11.10	+0.45%	239,077
24/08/26	NT$11.05	-2.64%	306,410
21/08/26	NT$11.35	+2.71%	477,658
20/08/26	NT$11.05	+1.38%	114,705

End-of-day quote Taiwan S.E.

More quotes

End-of-day quote Taiwan S.E. 25/08/2026			5-day change	1st Jan Change
11.10 ^TWD	+0.45%		+3.26%	-17.78%

08-04	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-03	PhytoHealth's Revenue Rises 18% in May	MT

Market Cap	2.25B 70.66M 60.55M 56.74M 51.83M 97.81M 6.74B 98.77M 669M 261M 3.4B 265M 260M 11.26B	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	1.21B 37.78M 32.38M 30.34M 27.71M 52.3M 3.6B 52.81M 358M 139M 1.82B 142M 139M 6.02B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.14%	Yield 2024 *	-	Yield 2025	-

08-04	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/09/25	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
13/08/25	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
06/05/25	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
05/05/25	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
04/05/25	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
27/02/25	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI

09/08/22	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
05/07/22	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
24/05/22	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
08/04/22	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
09/03/22	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Share Price

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation: PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases: PhytoHealth Corporation

Quotes and Performance

Price Extremes

Managers and Directors: PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

1 day	+0.45%
1 week	+3.26%
Current month	-1.77%
1 month	-5.53%
3 months	-11.55%
6 months	-21.83%
Current year	-17.78%

1 week	10.9	11.6
1 month	10.7	11.75
Current year	10.7	15.25
1 year	10.7	17.9
3 years	10.7	24
5 years	10.7	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	12/06/2017
Chih Yuan Huang DFI	Director of Finance/CFO	-	10/05/2021
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	29/07/2021

Director	Title	Age	Since
Cheng Chia Li CHM	Chairman	-	09/06/2011
Yue Ju Lai BRD	Director/Board Member	-	15/03/2010
Yi Li Lee CHM	Chairman	55	25/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	+0.45%	+3.26%	-14.94%	-44.08%	69.11M
REGENERON PHARMACEUTICALS, INC.	-1.75%	-2.57%	+39.41%	-1.40%	83.24B
MODERNA, INC.	-7.05%	-15.03%	+499.12%	+30.16%	63.41B
CSL LIMITED	-0.69%	+3.58%	-19.85%	-35.64%	59.49B
SAMSUNG BIOLOGICS CO.,LTD.	+0.76%	+3.53%	+0.08%	+36.18%	52.94B
UCB	-1.43%	+1.42%	+10.59%	+168.80%	49.86B
BIOGEN INC.	-0.22%	-0.39%	+61.43%	-16.73%	32.62B
INCYTE CORPORATION	-0.86%	+0.09%	+53.07%	+98.33%	26.29B
INNOVENT BIOLOGICS, INC.	+9.69%	+13.61%	+9.85%	+224.85%	22.23B
SWEDISH ORPHAN BIOVITRUM AB	-0.98%	-0.04%	+60.70%	+122.25%	17.22B
Average	-0.21%	+18.64%	+69.95%	+58.27%	40.74B
Weighted average by Cap.	-1.22%	+27.36%	+95.60%	+47.00%

	2024	2025
Net sales	154M 4.81M 4.12M 3.86M 3.53M 6.66M 459M 6.73M 45.59M 17.75M 232M 18.07M 17.68M 767M	135M 4.22M 3.61M 3.39M 3.09M 5.84M 402M 5.9M 39.95M 15.55M 203M 15.84M 15.49M 672M
Net income	-73.5M -2.3M -1.97M -1.85M -1.69M -3.19M -220M -3.22M -21.82M -8.49M -111M -8.65M -8.46M -367M	-58.2M -1.82M -1.56M -1.46M -1.34M -2.53M -174M -2.55M -17.28M -6.73M -87.75M -6.85M -6.7M -291M
Net Debt	-1.06B -33.29M -28.52M -26.73M -24.41M -46.07M -3.17B -46.53M -315M -123M -1.6B -125M -122M -5.3B	-1.05B -32.88M -28.18M -26.4M -24.12M -45.51M -3.13B -45.96M -311M -121M -1.58B -123M -121M -5.24B